Colowick Alan
Insider transactions at 3 companies
This page shows all SEC Form 4 filings attributed to Colowick Alan. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| ALMS | Purchase | 16,104 | $6.97 | $112,245 | Apr 2, 2025 | |
| 0001708493 | Award / Grant | 16,456 | — | — | Apr 1, 2023 | |
| PSNL | Award / Grant | 10,770 | — | — | May 17, 2022 | |
| PSNL | Award / Grant | 2,736 | — | — | May 14, 2021 | |
| 0001510487 | Option Exercise | 7,500 | $4.54 | $34,050 | Jul 1, 2020 | |
| 0001510487 | Sale | 6,660 | $60.00 | $399,600 | May 1, 2020 | |
| GERN | President, Oncology | I | 2,705 | $5.73 | $15,500 | Jan 2, 2008 |
| GERN | President, Oncology | Tax Withholding | 3,575 | $7.78 | $27,814 | Oct 16, 2007 |
| GERN | President, Oncology | Award / Grant | 12,734 | — | — | May 23, 2007 |
| GERN | President, Oncology | I | 323 | $8.76 | $2,829 | Jan 3, 2007 |